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Abstract
Background: Cortisol is frequently used as a marker of physiologic stress levels. Using cortisol for that purpose, however,
requires a thorough understanding of its normal longitudinal variability. The current understanding of longitudinal
variability of basal cortisol secretion in women is very limited. It is often assumed, for example, that basal cortisol profiles do
not vary across the menstrual cycle. This is a critical assumption: if cortisol were to follow a time dependent pattern during
the menstrual cycle, then ignoring this cyclic variation could lead to erroneous imputation of physiologic stress. Yet, the
assumption that basal cortisol levels are stable across the menstrual cycle rests on partial and contradictory evidence. Here
we conduct a thorough test of that assumption using data collected for up to a year from 25 women living in rural
Guatemala.
Methodology: We apply a linear mixed model to describe longitudinal first morning urinary cortisol profiles, accounting for
differences in both mean and standard deviation of cortisol among women. To that aim we evaluate the fit of two
alternative models. The first model assumes that cortisol does not vary with menstrual cycle day. The second assumes that
cortisol mean varies across the menstrual cycle. Menstrual cycles are aligned on ovulation day (day 0). Follicular days are
assigned negative numbers and luteal days positive numbers. When we compared Models 1 and 2 restricting our analysis to
days between 214 (follicular) and day 14 (luteal) then day of the menstrual cycle did not emerge as a predictor of urinary
cortisol levels (p-value .0.05). Yet, when we extended our analyses beyond that central 28-day-period then day of the
menstrual cycle become a statistically significant predictor of cortisol levels.
Significance: The observed trend suggests that studies including cycling women should account for day dependent
variation in cortisol in cycles with long follicular and luteal phases.
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Introduction
Stress has been described as one of the most significant health
problems in the 21
st century [1]. The physiologic response to stress
is mediated by the hypothalamic-pituitary-adrenal axis (HPAA).
HPAA function is linked to critical metabolic tasks such as
immune response, cardiovascular function, reproductive physiol-
ogy, and general well-being [2–5]. Understanding the basic
function of this axis is, therefore, of critical importance both to
monitor physiologic stress levels and to understand the pathways
that link stress with negative health outcomes.
Cortisol is one of the most important end products of HPAA
activation [6]. Energetic, health and psychosocial challenges lead
to increases in this glucocorticoid’s levels [7–9] and is, thus,
frequently used to evaluate physiologic stress levels within and
between individuals. When stimulated by endogenous and
exogenous challenges, the paraventricular nucleus of the hypo-
thalamus increases its production of corticotropin-releasing
hormone (CRH), which in turn promotes the release of
adrenocorticotropin (ACTH) by the anterior pituitary, leading to
an increase in the secretion of glucocorticoids, including cortisol,
by the adrenal cortex. Increases in cortisol levels trigger
gluconeogenesis, resulting in higher levels of circulating glucose.
Glucose provides energy to the tissues involved in responding to
the challenges that trigger the activation of the HPAA in the first
place [3]. Thus, cortisol levels are frequently used to monitor
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physiologic stress levels [10–12].
Yet, since the secretion of cortisol is affected by numerous
factors its use as a marker of physiologic stress is not simple and
should always be accompanied by proper controls [13–17]. One of
these factors is the sex of an individual. In both sexes the
neuroendocrine axes regulating stress response and reproductive
function (the hypothalamic-pituitary-gonadal axis or HPGA) are
intimately interconnected [18–20]. In women, however, the
HPGA continuously transitions across reproductive stages and
these changes appear to be associated with changes in HPAA
functioning. Late pregnancy, for example, appears to be
accompanied by hypercortisolemia [21] and the early post-partum
period is characterized by changes in cortisol baseline levels and
stress responsivity [22–25]. Thus, it is obviously important to
consider women’s reproductive status when assessing variations in
HPAA function and physiologic stress levels. Nonetheless, our
understanding of HPAA function is quite incomplete as we still
lack a proper characterization of the changes in HPAA
functioning across most reproductive transitions.
Longitudinal changes in HPAA functioning across women’s
menstrual cycles, for example, are yet to be properly character-
ized. It is often assumed that stress responsivity varies across the
menstrual cycle but that baseline cortisol does not [26]. This is a
critical assumption as it plays a vital role in the development of
study designs of research focused on stress physiology and
statistical analysis of the resulting data [6,27]. If basal cortisol
does not vary across the menstrual cycle then studies assessing
HPAA functioning or stress physiology would not need to control
for day of the menstrual cycle. In that case, individual basal
cortisol levels could be simply assessed by collecting a small
number of random specimens at any time during the menstrual
cycle.
Despite the importance of this assumption to research on stress,
however, the evidence suggesting that baseline cortisol levels do
not vary across the menstrual cycle is scarce and contradictory.
Most previous studies analyzing baseline cortisol levels across
menstrual cycles have been conducted using cross-sectional
designs, have been focused on particular days or narrow time
windows within the cycle, and have been based mainly on two
matrices with important limitations: blood and saliva. The ideal
method with which to assess longitudinal variation in basal cortisol
secretion across the menstrual cycle is to follow individual women
across several menstrual cycles collecting bio-specimens as
frequently as possible. Blood and saliva may not be the most
appropriate matrices for these types of studies. Circulating levels of
cortisol change rapidly. Thus, blood and saliva concentrations of
this glucocorticoid are affected by instantaneous HPAA responses
to any of a broad variety of ephemorous challenges. Some
participants may, for example, experience an increase in cortisol
levels triggered by the anticipatory anxiety generated by the
impending prick that precedes blood collection. Additionally,
blood collection is invasive, uncomfortable and carries a risk of
infection, which makes it a poor choice for long-term studies that
require repetitive sampling. The collection of saliva is less invasive
and comparatively easier than that of blood. In fact, saliva has
been successfully used in combination with experimental stress
challenges to assess stress reactivity in different phases of the
menstrual cycle [18,28,29]. Yet its use in non-experimental
settings is complicated by the numerous non-stress related
ephemorous factors that can affect cortisol levels, including
normal physical activity and the consumption of food, caffeine,
or alcohol [13–17]. Thus, despite its advantages for the
experimental evaluation of stress reactivity, saliva has clear
limitations as a matrix with which to assess basal cortisol profiles
longitudinally in natural settings.
First morning urine, on the other hand, provides an integrated
measure of overnight cortisol secretion, a time period that is less
likely to be affected by the ephemorous, mostly diurnal,
confounders mentioned above. Furthermore, as urine can be
self-collected and collection is relatively non-invasive, it is a matrix
that lends itself to be used in designs that involve repetitive
sampling across long time periods.
Here we present longitudinal analyses of cortisol levels in first
morning urinary specimens provided by Kakchiquel women from
rural Guatemala. These analyses contribute to our understanding
of basal HPAA functioning across women’s reproductive transi-
tions and provide critical information on the use of a matrix that
lends itself to naturalistic longitudinal studies while, simultaneous-
ly, reducing the effect of relatively ephemorous confounding
factors. Our results will be useful in informing study designs and
protocols involving cortisol as a marker of HPAA function and
evaluating physiologic stress in women across the menstrual cycle.
Results
We first fit the proposed models only to the data collected
during the 28 days traditionally considered to be the length of
standard menstrual cycles (days 214# ovulation #14). When only
those data were included in the analyses we found no evidence that
either Model 2i nor Model 2ii fit better than Model 1 (p-
values=0.098 and 0.161, respectively). In other words, our results
provide no evidence that cortisol level varied by day of the
menstrual cycle during cycle days 214#t#14. However, when we
used the entire data set (including the data from follicular and
luteal phases that lasted more than 14 days), we found evidence
that Model 2i and Model 2ii fit better than Model 1 (p-
values=0.041 and 0.009, respectively). These results imply that
in cycles with long follicular and luteal phases (.14 days) cortisol
levels vary with the day of the menstrual cycle. Figures 1 and 2
illustrate the fitted mean cortisol levels based on Model 2i and
Model 2ii, respectively. These figures suggest that the observed
variation in overnight excretion of cortisol levels may be explained
by differences characterizing the onset and last days of long
menstrual cycles. Our sample size, however, did not permit the
formal investigation of which days or set of days were significantly
different in terms of mean cortisol levels.
Discussion
To our knowledge, this is the first longitudinal description of
first morning urinary cortisol levels across the full menstrual cycle
in humans. Our analyses suggest that day of the menstrual cycle is
a significant predictor of first morning urinary cortisol levels in
cycles with follicular or luteal phases lasting longer than 14 days.
Our sample size does not allow us to determine which specific days
during the menstrual cycle differ in terms of cortisol secretion.
However, the lack of significant differences in cortisol means when
we restrict our analyses to the 14 days immediately preceding and
following ovulation suggest that the differences in cortisol levels
occur beyond the central 28 day period.
Animal studies suggest that sex steroids could affect basal HPAA
functioning [30]. Female rats exhibit higher glucocorticoid levels
(corticosterone) during proestrus, when estradiol is higher, than
during estrous [31–33]. Furthermore, experimental ovariectomy
leads to a fall in corticosterone, which is resolved via the
administration of exogenous estradiol [34,35]. Yet the association
observed between sexual steroids and HPAA functioning in rats
may not be directly extrapolable to the human case. While there is
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women [18,28,36], basal cortisol levels are commonly assumed not
to vary across the menstrual cycle [26]. This assumption, however,
rests on limited and contradictory evidence.
Results from previous human studies evaluating variation in
basal cortisol levels across menstrual cycle range broadly. Some
studies find no differences between menstrual cycle phases, while
others report higher cortisol levels in either the follicular or the
luteal phase or within phase changes in basal cortisol levels. Most
of these studies use blood or saliva as their matrix. Symonds and
colleagues, for example, report no significant differences in cortisol
levels assessed in salivary specimens collected one day at mid-
follicular and one day at mid-luteal [37]. Similarly, Kudielka and
Kirschbaum [6] report no effect of menstrual cycle phase on
cortisol in salivary samples taken directly after awakening as well
as 15, 30, 45, and 60 minutes thereafter. In one of the few studies
based on daily blood samples, Saxena and colleagues [38]
evaluated cortisol levels across the menstrual cycle in 6 healthy
women. The blood specimens collected between 7 am and 8 am
between days 211 to +11 of the menstrual cycles showed no cyclic
variations in cortisol levels. These and other studies with similar
results [39–41] have led to the common assumption that there is
no variation in basal cortisol levels across the menstrual cycle.
In contrast, other researchers using the same matrices do report
variations in cortisol levels across the menstrual cycle. Genazzani
and colleagues [42] collected blood specimens from 5 women
experiencing ‘‘regular’’ menstrual cycles. Their protocol asked that
blood be drawn at 7:30 am after a light breakfast between days
211 and +14 of the menstrual cycle. They report significant
differences within the follicular phase with cortisol lower between
days 27 and 24 and higher on day 22. Beck and colleagues [43]
evaluated adrenocortical function 10 and 24 days after the last
menstrual period and also report cortisol in plasma to be
significantly higher in the sample collected during the follicular
phase.
The lack of consistency in results is likely a consequence of the
wide variability in designs and methods across studies, combined
with relatively small sample sizes and the limitations of the
matrices used. For example, sampling schedules and protocols can
have a significant impact on the level of within and between
individuals’ variability in cortisol levels when using blood or saliva.
Cortisol secretion follows circadian patterns and can be affected by
the participants’ wake up time, the time elapsed between wake-up
time and the collection of the sample, and the events that took
place in that interval. To reduce the influence of these
confounders, early studies based on blood specimens scheduled
specimens’ collection very early in the morning and mostly before
participants had breakfast (e.g. [40,42,43]). However, controlling
for the stimuli that women are exposed to between that time and
the moment they arrive at the laboratory to get their blood drawn
is extremely difficult. Furthermore, the prospect of having blood
extracted can act, for some participants, as a stressor itself. All of
these factors introduce variability in the data obtained, reducing
statistical power and, with it, the ability of researchers to detect
changes in basal adrenocortical cortisol secretion across the
menstrual cycle. Some teams have attempted to solve these issues
by working with saliva which, as it can be self-collected, can be
obtained immediately after women wake up each morning (e.g.
[6,37]). Loose adherence to the sampling schedule by participants,
however, leads to the same problems of differential exposure to
Figure 1. Observed and fitted cortisol profiles using Model 2i. The thick black line represents the fitted means for Model 2i and the dotted
lines represent the standard errors for the individual estimated means. The thin black line represents the observed average cortisol levels for each
menstrual cycle day.
doi:10.1371/journal.pone.0018242.g001
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menstrual cycle evaluated. Many of the previous studies have been
based on single or, in some cases, a few samples collected at
specific days during each menstrual cycle phase. Our results and
those of Genazzani and colleagues [42] suggest, however, that
there may be a significant amount of variation in cortisol secretion
within each phase. Thus, cortisol levels assessed on specific days
may not represent mean phase levels and do not provide
information about within phase variability or the longitudinal
profile of cortisol secretion across each phase. A related problem is
that day of the menstrual cycle is frequently imputed by counting
days since the onset of the last menstrual bleeding (e.g. [6,37,44]).
This method, however, is quite inaccurate in terms of identifying
the timing of the biologic processes that may ultimately affect
cortisol secretion, such as the stage of follicular development or
ovulation [45]. Inaccuracies in the identification of key biologic
events during the menstrual cycle introduce yet another source of
variability, increasing the risk of committing a type II statistical
error (i.e., failing to detect differences in cortisol production
between menstrual cycle phases).
Our study design helped to reduce the effect of several of the
problems described above. We used a longitudinal approach
including complete menstrual cycles (in most cases more than one
per participant) and first morning urine to assess both cortisol and
reproductive hormones (LH, FSH, E1C and PdG) to impute
menstrual cycle day using a key reproductive event (day of
ovulation). This methodology presumably increased our statistical
power, aiding in the detection of variation in overnight adrenal
production of cortisol in menstrual cycles with prolonged inter-
ovulatory-intervals (IOIs). The nature of our data precludes us
from exploring the proximate function (if any) of the observed
variations in cortisol level. The observed variation in overnight
cortisol level may either be directly involved in the physiologic
pathways leading to the prolongation of the IOI period or be a
consequence of said prolongation. Long IOIs can result from
prolonged follicular and/or luteal phases. HPAA activation can
lead to the prolongation of the follicular phase [46,47]. Thus, the
observed variability in cortisol levels in the early days of cycles of
long follicular phases could actually be the cause of the follicular
extension. On the other hand, HPAA activation is unlikely to
explain prolonged luteal phases. HPAA activation has been linked
to poor luteal function [47,48], which would result in an early
shedding of the endometrium and consequently shorter rather
than longer luteal phases. It could also be argued that the observed
variation in cortisol excretion may be linked to the implantation of
conceptuses that failed to produce detectable levels of human
chorionic gonadotrophin (hCG). Such conceptuses, however,
would fail to rescue the corpus luteum and, consequently, are
unlikely to lead to prolonged luteal phases.
Alternatively, the increased overnight cortisol excretion in long
IOIs may be explained by reproductive and immune processes
that take place during the transition between consecutive
menstrual cycles. Cortisol variability could be associated with an
exacerbation of inflammatory processes that accompany either the
multiple follicular waves that take place between ovulatory events
[49–51] or menstruation [52–54]. Previous studies provide
evidence that glucocorticoids play an important modulating role
in those inflammatory processes [52–54].
Figure 2. Observed and fitted cortisol profiles using Model 2ii. The thick black line represents the fitted means for Model 2ii and the dotted
lines represent the standard errors for the individual estimated means. The thin black line represents the observed average cortisol levels for each
menstrual cycle day.
doi:10.1371/journal.pone.0018242.g002
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menstrual cycle has important implications in terms of study
design and statistical analysis. For example, to obtain an unbiased
estimate of a woman’s typical cortisol level, cortisol measurements
must be taken throughout her menstrual cycle, namely, both
during the central 28 day window around ovulation, and on each
day outside of this window. Moreover, if cortisol is used as the
response variable in a regression model that does not account for
day of menstrual cycle, the estimates of the effects of the predictors
that do appear in the model will be biased. Thus, studies using
cortisol as a marker of physiologic stress levels in cycling women
should not disregard as a potential confounder the day of the
menstrual cycle in which a given sample has been collected.
Rather, statistical comparison of cortisol levels within and between
women should either be based on similar menstrual cycle days or
adjust for day of the menstrual cycle.
In sum, our results suggest that basal overnight cortisol secretion
vary across the menstrual cycle. First morning urine presents clear
advantages over blood and saliva as a matrix with which to
evaluate long-term longitudinal variations in basal cortisol levels
across women’s reproductive transitions. Our sample was collected
from a rural indigenous population with high ethnic homogeneity
and comparably less variability than other populations in terms of
physical schedules and energy intake. While small differences in
terms of absolute mean cortisol levels may exist among ethnic
groups, adrenal function and general secretion profiles are
expected to be universal across all women. It would however be
important to replicate our study in communities with higher levels
of ethnic heterogeneity and a broader range of energetic balances.
Larger sample sizes will be required to determine the specific
mathematical function describing mean cortisol levels across the
menstrual cycle. Our results, nonetheless, suggest that studies
involving the measurement of cortisol levels in cycling women
should account for day dependent variation in cortisol, particularly
in cycles with long follicular and luteal phases.
Materials and Methods
Study population and criteria for participant inclusion
This paper is based on data collected in the context of the
Society, Environment and Reproduction (SER) study. Fieldwork
took place over 12 months between the years 2000 and 2001 in a
rural Kaqchikel Mayan community located in the southwest
highlands of Guatemala. This community was composed at the
time of 1,159 inhabitants who were almost exclusively Kaqchikel
Mayan. All women within this population who fit the following
profile were invited to participate: living with a co-resident male
partner, not pregnant, not using any form of chemical contracep-
tive method, had given birth at least once in the past, and whose
last birth had taken place at least 6 months prior to the onset of the
study. Additional details on the characteristics of the population
have been reported elsewhere [48,55]. During the first half of the
study recruitment was restricted to women aged 18–32 years, but
later the upper age limit was expanded to 40 years to increase the
sample size.
The sample
Throughout the year, 61 women (about three-quarters of those
eligible) volunteered to participate. Twenty-five (25) of the 61
participants cycled at least once during the study and experienced
a total of 84 menstrual cycles (mean =3.4, SD=3.05, median =
2). Of these 84 menstrual cycles, 29 cycles had long follicular
phases (.14 days), 5 had long luteal phases (. days) and one cycle
had both long follicular and luteal phases. This summary of cycle
length data is, however, affected by the large number of
‘‘censored’’ cycles contained in our sample (41 out of 84). The
onset and end of each woman’s participation in our study were
unlikely to coincide with the first or last day of a cycle and, thus,
were unlikely to be full cycles. The analyses performed for this
paper are based on the data corresponding to the women who had
resumed ovarian function after their last birth. The ages of these
25 women ranged from 18–39 years but, because of the original
design, the age distribution was heavily weighted toward the mid-
20s (mean =25.4 years, SD=5.3 years, median =25 years).
This research was approved by the Research Ethics Board of
Simon Fraser University. As most individuals in the study
population were illiterate, informed consent from the participants
was obtained orally. The consent document was read in
Kakchiquel Mayan by a female research assistant (a native
Kakchiquel speaker) and signed by each volunteer with a cross,
finger print or name initials, according to her preference.
Data and specimen collection
Data and urine specimen collection were performed by trained
local female field assistants. Every other day, for a total of three
times each week, assistants visited participants in their homes and
gathered first morning urine samples. Following standard urine
collection protocols, urine specimens were collected by each
participant in clean, dry, nonreactive plastic containers that we
provided the night before. Samples were kept on ice until assistants
returned to the laboratory (,2 hours from the urinary void). Two-
ml aliquots from the original specimens were stored frozen at
210uC in the field. Samples were shipped on dry ice to the
CLASS laboratory at the University of Michigan, where they were
stored at 280uC until analysis.
Hormonal assays
Concentrations of urinary free cortisol, estrone conjugates
(E1C), pregnandiol glucuronide (PdG), luteinizing hormone (LH),
follicle stimulating hormone (FSH), and hCG were determined
using immunoassays developed in CLASS laboratory for use with
the Bayer Automated Chemiluminescence System (ACS-180)
immunoassay analyzer. Creatinine was assayed using a spectro-
photometric assay. All samples from a single participant were run
on the same assay and in duplicate. Outliers were identified and
the samples rerun. Ranges and intra- and inter-assay coefficients of
variation (IACV and IECV, respectively) were within acceptable
ranges. Creatinine: range =0.05–1.4 mg/ml, IACV =5.4%
IECV =9.8%; cortisol: range =0.2–75 mg/dl, IACV =2.0%,
IECV =6.5%; E1C: range =5.10–408.0 ng/ml, IACV =3.8%,
IECV =6.5%; PdG: range =0.005–25.5 mg/ml, IACV =3.6%,
IECV =11.6%; LH: range =0.1–53.1 mIU/ml, IACV =3.5%,
IECV =5.4%; FSH: range =0.3–144.0 mIU/ml, IACV =2.3%,
IECV =5.8% [48].
Data analysis
Characterization of menstrual cycles and cycle day
attribution. To control for urine dilution we divided the
concentration of each hormone by the concentration of
creatinine in the same sample. We then log transformed the
creatinine corrected hormonal measurements, after which the data
became approximately normally distributed. Log transformed
creatinine corrected hormone levels were used for all our statistical
analyses and thus, from this point forward, are simply referred to
as cortisol.
Menstrual cycles were considered to begin on the first day of
vaginal bleeding and end the day before the next bleeding. If
Cortisol Excretion Across the Menstrual Cycle
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last day of the cycle to the day in which PdG levels fell to 40% of
its luteal peak and remained low for $2days [48]. Cycles
presenting a 3-fold rise in PdG levels above baseline were
considered ovulatory [56]. The time of ovulation was inferred
using an algorithm based on the urinary ratio of E1C/PdG [57]
and verified using the presence of LH and FSH surges. Menstrual
cycles were aligned to the estimated day of ovulation, which was
designated ‘‘day 0.’’ Follicular days were given negative numbers
and luteal days positive numbers.
Confounding factors. Cortisol secretion can be affected by
circadian rhythms, physical activity, food consumption, smoking,
caffeine, alcohol, and steroid medications [13–17]. First morning
specimens provide a proxy for overnight cortisol excretion.
Working with overnight cortisol excretion minimizes the effects
that circadian rhythms have on this metabolite’s profile. None of
the participants smoked or consumed alcohol. Urine samples were
collected as soon as the participants woke up each morning and
before they consumed food or performed any major physical
activity, eliminating the influence of those confounders. Our
sample of women was relatively homogeneous in terms of age.
Thus, we did not evaluate the possible impact of age on cortisol
levels in our models. See also Nepomnaschy et al. (2004) [48].
Statistical analysis
We compared two linear mixed models for cortisol. Mixed
models take into account both fixed (e.g., day of the menstrual
cycle) and random (individual participant) effects. The random
effect captures the effects of unmeasured variables that might
explain some of the differences in cortisol among women, thus
controlling for possible correlations among cortisol measurements
from the same woman.
Model 1 assumed that there was no variation in mean cortisol
across the menstrual cycle. Specifically, we assumed:
Yit~mzuizeit,
where Yit is the cortisol measurement on woman i on day t, m is
the overall mean cortisol level, ui is the effect on the overall mean
for woman i, and eit is the random error for woman i on day t.
Furthermore, we assumed that:
ui is drawn from a normal distribution with mean 0 and
variance t2
u
eit is drawn from a normal distribution with mean 0 and
variance s2
i
s2
i is drawn from a gamma distribution with parameters
common across women.
This model assumes that the mean cortisol level (m) is flat across
the menstrual cycle, but that this mean may differ among women
(i.e., the mean level for woman i is mzui). The random variable eit
captures random error in the cortisol values (including increases
due to stressful events). Data were plotted longitudinally by
participant. Visual inspection of the resulting menstrual cycles
profiles suggest that the amount by which cortisol fluctuates
around the mean differs across women. Some women, in
particular, have nearly identical measurements over time, whereas
others have highly variable measurements. For this reason, we
allow the variance of eit to vary among women (according to a
gamma distribution).
Model 2 is similar to Model 1, but in this case mean cortisol is
allowed to vary as a function of time across the menstrual cycle. In
particular, we let
Yit~mft ðÞzuizeit:
We evaluated two versions of this last model. In version 2i of this
model cortisol means were estimated for each day between days
219 and 14, inclusive. Outside this period we had very few
observations for some days (,8 observations for each day). Thus,
to avoid problems with parameter estimation we defined the
following time windows: day,=227, 227,day,=224,
224,day,=222, 222,day,=220, day.14. We allowed
mean cortisol level to vary among time windows, but assumed that
the mean was constant within each window. See Figure 1.
For version 2ii we defined 3-day windows across the menstrual
cycle except at the extremes of the distribution of follicular and
luteal days where we grouped days into two windows: ‘‘very early
follicular days’’ (days #227) and ‘‘very late luteal days’’ (days .
15). Again, we allowed mean cortisol to vary among these windows
but assumed that it remained constant within each window. Model
2ii has fewer parameters than Model 2i, possibly providing more
power to detect differences among cortisol means across the
menstrual cycle. The disadvantage of Model 2ii is that it assumes
that cortisol profiles are flat over each 3 day window. See Figure 2.
No other formal analyses of cycle day effect were conducted.
However, before deciding that our proposed longitudinal model
provided a reasonable description of the data, we explored
alternative models. Specifically, we fitted a standard linear mixed
model (i.e. with common variability of cortisol across women), but
the model allowing differences in cortisol variability across women
seemed to fit better and was therefore preferred over the standard
model. We also used (informal) graphical methods for two
purposes. First, we looked for, but did not find, an obvious
autocorrelation structure describing the cortisol measurements on
individual women (a finding consistent with the assumptions of our
final model). Second, we checked whether other variables such as
age and a recent previous pregnancy loss could explain cortisol
patterns or outliers but found no evidence of such associations.
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